Table 3.
Intervention (N = 113) | Usual care (N = 109) | ||||
---|---|---|---|---|---|
Cost price | Volume | Costs | Volume | Costs | |
CDSS | |||||
Development (h) | 36 | 144 | 5184 | – | – |
Implementation | |||||
Researcher (h) | 54 | 4 | 216 | – | – |
Nurse (number × h) | 40 | 20 × 2 | 1600 | – | – |
Total costs CDSS implementation | 7000 | ||||
ED visit | |||||
Physician (h × visit number) | 68 | 0.33 × 113 | 2535 | 0.33 × 109 | 2445 |
Nurse (h × visit number) | 40 | 0.5 × 113 | 2260 | 0.5 × 109 | 2180 |
Hospital costs | 114 | 113 | 12,882 | 109 | 12,426 |
Diagnostics | |||||
Electrolytes | 3.8 | 15 | 57 | 23 | 87 |
Acid-base balance | 5.10 | 13 | 66 | 16 | 82 |
Treatment | |||||
Unknown | 6 | 11 | |||
ORS portion | 0.3 | 73 | 22 | 57 | 17 |
Liquid other | NA | 18 | NA | 30 | NA |
ORS nasogastric tube | 28.2 | 17 | 479 | 9 | 254 |
IV rehydration | 5.0 | 0 | 5 | 2 | 10 |
Follow-up/hospitalization | |||||
Hospitalization patients × (LOS days) | 575 | 10 × 2 | 11,500 | 7 × 2 | 8050 |
Outpatient clinic | 129 | 25 | 3225 | 26 | 3354 |
Telephonic follow-up | 20 | 21 | 420 | 15 | 300 |
Costs of missed diagnoses/adverse events | |||||
Revisit ED | 144 | 30 | 4464 | 30 | 4320 |
Admission after revisit (LOS days × patients) | 575 | 2 × 1 | 1150 | 2 × 4 | 4600 |
Mean costs per patient (including CDSS) | 408 | 350 | |||
Mean costs per patient (without CDSS) | 346 | 350 |
Currency rate EUR/USD 1.11; 8th Nov 2016
LOS length of stay